A Nagoya-based venture has started selling a reagent that allows researchers to significantly reduce the time needed to synthesize proteins, supporting the development of medicines including one that can control the growth of cancer cells.
The reagent sold by NUProtein Co., which originated from Nagoya University, was developed by a 28-year-old female postgraduate student who came up with her own way of synthesizing proteins and ended up commercializing the process after drawing attention from universities and research institutions.
In research, proteins are used to check allergic reactions and the effects of medicines for various illnesses.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.